Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial glycosidases (glycoside hydrolases) are a large and diverse group of enzymes that catalyze the cleavage of glycosidic bonds in carbohydrates, playing central roles in the degradation of complex glycans, remodeling of bacterial cell walls, and utilization of dietary polysaccharides. They are classified into many families (e.g., GH22, GH24, GH25 for lysozymes; others for metabolic glycosidases) according to the CAZy database based on sequence, fold, and catalytic mechanism. Bacterial glycoside (sugar) transporters are equally diverse, mediating the import of mono-, oligo-, and polysaccharides into bacterial cells for metabolism and growth. Major classes include ATP-binding cassette (ABC) transporters, phosphotransferase systems (PTS), major facilitator superfamily (MFS) transporters, and starch utilization system (SusCD) proteins. Both glycosidases and transporters are cooperative components of bacterial carbohydrate utilization loci (PULs), which allow bacteria to adapt to complex environmental substrates. These protein classes are important in host–microbe interactions, bacterial pathogenesis, and have roles as potential drug targets for modulation of the microbiome or treatment of infectious diseases. Note: For structured database use, refer to individual enzymes (e.g., "N-acetylmuramidase" for lysozyme) or transporters (e.g., "ABC transporter, subfamily X"), rather than broad classes, to achieve precise target identification.
Competitive or noncompetitive inhibition of glycosidases (prevents carbohydrate breakdown) Blockage or modulation of transporter activity (impairs nutrient uptake or efflux) Disruption of bacterial metabolism (synergistic with antibiotics or as standalone agents)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial glycosidase and transporter.